Ellen K. Ritchie

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2018 · 990 citations · Full text

Medicine, Oncology, Pharmacology +15

Somatic mutations precede acute myeloid leukemia years before diagnosis

Pinkal Desai, Nuria Mencia-Trinchant, Oleksandr Savenkov et al. · Nature Medicine · 2018 · 615 citations

Medicine, Molecular Genetics, Oncology +13

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes et al. · The Lancet Oncology · 2017 · 488 citations · Full text

Medicine, Oncology, Pharmacology +10

Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier et al. · Journal of Clinical Oncology · 2017 · 446 citations · Full text

Medicine, Hematology, Oncology +16

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

Jörge E. Cortes, Philippe Rousselot, Dong‐Wook Kim et al. · Blood · 2006 · 418 citations

Medicine, Hematology, Oncology +16